ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

SYRE Spyre Therapeutics Inc

23,51
0,80 (3,52%)
28 Juin 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 6 176 408
Prix Achat 23,37
Prix Vente 26,72
Actualités -
Maximum Haut 23,96

Bas
10,42

Sur 52 semaines

Haut
47,97

Minimum Bas 22,32
Nom Action Symbole Action Marché Type
Spyre Therapeutics Inc SYRE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,80 3,52% 23,51 23:50:26
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
22,80 22,32 23,96 23,51 22,71
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
14 090 6 176 408 US$ 23,06 US$ 142 435 714 - 10,42 - 47,97
Dernière Transaction Type Quantités échangées Prix transaction Devise
22:49:48 average 68 000 US$ 23,51 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
1,19B 50,78M - 886k -338,79M -6,67 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Spyre Therapeutics

Date Heure Source Titre
18/6/202413:30PR Newswire (US)Spyre Therapeutics Announces First Participants Dosed in..
03/6/202423:23PR Newswire (US)Spyre Therapeutics Announces Grants of Inducement Awards
30/5/202422:33Edgar (US Regulatory)Form 8-K - Current report
29/5/202414:30PR Newswire (US)Spyre Therapeutics to Participate in the Jefferies Global..
16/5/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
15/5/202413:40Edgar (US Regulatory)Form 8-K - Current report
15/5/202413:30PR Newswire (US)Spyre Therapeutics Appoints Accomplished Biopharma Leader..

Forum Action Spyre Therapeutics

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Spyre Therapeutics Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine25,8826,5422,1923,561 003 581-2,37-9,16%
1 mois34,4538,9022,1927,84807 550-10,94-31,76%
3 mois35,6040,83522,1931,12468 183-12,09-33,96%
6 mois20,2447,9718,5431,27474 1213,2716,16%
1 an10,8147,9710,4230,57427 78112,70117,48%
3 ans10,8147,9710,4230,57427 78112,70117,48%
5 ans10,8147,9710,4230,57427 78112,70117,48%